<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/14BCAFCF-CA4E-40B6-B642-523A987BACD0"><gtr:id>14BCAFCF-CA4E-40B6-B642-523A987BACD0</gtr:id><gtr:name>Royal College of Obstetricians and Gynaecologists (RCOG)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF"><gtr:id>1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF</gtr:id><gtr:name>Perinatal Ireland</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5708F929-148B-4ACC-826D-4143C2B329C0"><gtr:id>5708F929-148B-4ACC-826D-4143C2B329C0</gtr:id><gtr:name>March of Dimes Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DA520CA9-17B1-4166-A89C-915E6A74BFE3"><gtr:id>DA520CA9-17B1-4166-A89C-915E6A74BFE3</gtr:id><gtr:name>Norwegian Institute of Public Health</gtr:name><gtr:address><gtr:line1>Norwegian Institute of Public Health</gtr:line1><gtr:line2>PO Box 4404 Nydalen</gtr:line2><gtr:postCode>N-0403</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2824881B-4B7F-44BA-A463-4CC82DFDB3D4"><gtr:id>2824881B-4B7F-44BA-A463-4CC82DFDB3D4</gtr:id><gtr:name>Patient-Centered Outcomes Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>School of Clinical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/14BCAFCF-CA4E-40B6-B642-523A987BACD0"><gtr:id>14BCAFCF-CA4E-40B6-B642-523A987BACD0</gtr:id><gtr:name>Royal College of Obstetricians and Gynaecologists (RCOG)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF"><gtr:id>1DD10A0C-161C-41BD-8C2D-AD8FF538CCBF</gtr:id><gtr:name>Perinatal Ireland</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5708F929-148B-4ACC-826D-4143C2B329C0"><gtr:id>5708F929-148B-4ACC-826D-4143C2B329C0</gtr:id><gtr:name>March of Dimes Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DA520CA9-17B1-4166-A89C-915E6A74BFE3"><gtr:id>DA520CA9-17B1-4166-A89C-915E6A74BFE3</gtr:id><gtr:name>Norwegian Institute of Public Health</gtr:name><gtr:address><gtr:line1>Norwegian Institute of Public Health</gtr:line1><gtr:line2>PO Box 4404 Nydalen</gtr:line2><gtr:postCode>N-0403</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2824881B-4B7F-44BA-A463-4CC82DFDB3D4"><gtr:id>2824881B-4B7F-44BA-A463-4CC82DFDB3D4</gtr:id><gtr:name>Patient-Centered Outcomes Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A151F2D6-ACEB-4828-81A3-0DD519A99D76"><gtr:id>A151F2D6-ACEB-4828-81A3-0DD519A99D76</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Shennan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EA1A021B-0494-46D4-8944-16A06A168152"><gtr:id>EA1A021B-0494-46D4-8944-16A06A168152</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Courtenay</gtr:otherNames><gtr:surname>Robson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4A606E1D-6DFA-421F-850B-633910FA5299"><gtr:id>4A606E1D-6DFA-421F-850B-633910FA5299</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Sebire</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/682E1E65-69B9-4B23-95C3-792F52F53961"><gtr:id>682E1E65-69B9-4B23-95C3-792F52F53961</gtr:id><gtr:firstName>Stavros</gtr:firstName><gtr:surname>Petrou</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1B57DD47-4242-4081-AE60-A124A6D80305"><gtr:id>1B57DD47-4242-4081-AE60-A124A6D80305</gtr:id><gtr:firstName>Phillip</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Bennett</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3790EBA5-2C59-4BD3-983B-FECBD02A3B18"><gtr:id>3790EBA5-2C59-4BD3-983B-FECBD02A3B18</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Norman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7208400B-6791-4400-A90A-059F08720740"><gtr:id>7208400B-6791-4400-A90A-059F08720740</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Marlow</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9ED0F1CA-38BA-4436-91AC-421777202D73"><gtr:id>9ED0F1CA-38BA-4436-91AC-421777202D73</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Norrie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9B03F21D-20CE-4E8A-8011-2145D2DB53C4"><gtr:id>9B03F21D-20CE-4E8A-8011-2145D2DB53C4</gtr:id><gtr:firstName>Tina</gtr:firstName><gtr:surname>Lavender</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2342776B-F29A-4A23-A173-CB5072FC10DB"><gtr:id>2342776B-F29A-4A23-A173-CB5072FC10DB</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:surname>Thornton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700452"><gtr:id>4292D0D3-DDB8-4008-80E4-C1CAB80CF41C</gtr:id><gtr:title>Does progesterone prophylaxis to prevent preterm labour improve outcome? (OPPTIMUM)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700452</gtr:grantReference><gtr:abstractText>Preterm delivery is the biggest single cause of death and disability amongst babies born in the UK. At present, no drug treatment has been demonstrated to improve the outcome for babies by preventing the onset of preterm labour. It has recently been shown that a natural hormone called progesterone may reduce the risk of preterm delivery by around 50%. In the proposed study, we will confirm or refute this effect on preterm delivery and more importantly determine whether it improves the outcome for the baby and child. Pregnant women at high risk of preterm delivery who agree to take part will be given either a progesterone or a placebo (dummy) pessary daily from 22-24 until 34 weeks of pregnancy. We will record when the woman gives birth, whether the baby survives, and if so its immediate health (including any brain damage or lung disease) and health at two years of age using a developmental assessment scale. We will also calculate the costs of NHS treatment. We hope to show that progesterone treatment reduces the risk of preterm birth, that it improves baby?s immediate health, it is associated with improved thinking ability of the child at two years, and it reduces NHS costs overall.</gtr:abstractText><gtr:technicalSummary>Background:
Preterm delivery is the single biggest cause of perinatal mortality and morbidity, accounting for 75% of neonatal deaths. Two recent studies (da Fonseca et al. 2003; Meis, et al. 2003) and four meta-analyses (Sanchez-Ramos et al. 2005; Dodd, et al. 2005; Mackenzie et al 2006, Coomaraswamy et al 2006) have suggested that progesterone prevents preterm delivery in high risk women with singleton pregnancy. However, none of the meta-analyses demonstrated a convincing effect on perinatal mortality or morbidity and no studies have examined the important longer-term neurodevelopmental outcomes. We therefore concur with the conclusions of most of the meta-analyses and editorials that the routine use of progestational agents cannot be justified without evidence of improved outcomes for babies. 

Rationale for trial:
The proposed trial will quantify the magnitude of the obstetric, neonatal and child health benefits of vaginal progesterone treatment and evaluate the cost effectiveness of treatment.

Design of trial in high-risk women:
Women will be recruited if there is an appropriate history or a short (less than 25 mm) cervix on ultrasound scan and a positive fetal fibronectin (fFN). Women will be randomised to receive either vaginal progesterone 200mg, or placebo, from 22 weeks gestation daily until 34 weeks gestation. The primary obstetric outcome is delivery before 34 weeks of gestation. The primary neonatal outcome is a composite of death and major morbidity. The primary childhood outcome is neurodevelopmental performance at 2 years of age (Bayley 2006). A formal economic evaluation is a key part of this study. 

Implications for practice:
The results will be used to inform policy and practice by determining the clinical and cost effectiveness of progesterone for obstetric, neonatal and childhood outcomes in women at high risk of preterm birth. We will use an inexpensive generic formulation of natural progesterone so the results can be immediately translated into improved patient care if progesterone administration is indicated.

Expertise and personnel:
The applicants include obstetricians and neonatologists (with expertise in both preterm labour and in conducting clinical trials), statisticians, clinical triallists, a health economist, an expert on ascertaining consumer views. We have benefited from advice from lay collaborators. Thirty centres in the UK, with a combined annual delivery rate of 140,000 births have agreed to participate in this trial.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2189872</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Patient-Centered Outcomes Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>EPPPIC Collaboration</gtr:description><gtr:id>EB04C70C-AAF2-4E3C-98EC-ACB90E6AD8E6</gtr:id><gtr:impact>A protocol to do an IPD.
Disciplines include statistics, patient perspectives as well as pregnancy research.</gtr:impact><gtr:outcomeId>58bc5cd5f11282.66201515-1</gtr:outcomeId><gtr:partnerContribution>March of Dimes then lobbied PCORI who subsequently commissioned and funded the project.</gtr:partnerContribution><gtr:piContribution>This was a collaboration stimulated by the publication of the OPTIMUM study, which contradicted some of the existing literature on progesterone prophylaxis to prevent preterm birth. The collaboration aims to perform an IPD of the world literature on progesterone to prevent preterm birth. The collaboration has been commissioned and funded by PCORI (the Patient Centered Research Initiative, USA). University of York are performing the IPD. I lobbied March of Dimes to set up this IPD, March of Dimes then lobbied PCORI who subsequently funded the project.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>March of Dimes Foundation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>FIGO/March of Dimes collaboration</gtr:description><gtr:id>BE8AB537-0275-4D33-BA4C-4F1D90EC81C2</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>550177e947b2d4.30007738-2</gtr:outcomeId><gtr:partnerContribution>Intellectual contribution to questions on preterm birth causes and analysis of data
Funding of contract research organisation</gtr:partnerContribution><gtr:piContribution>Intellectual contribution to questions on preterm birth causes and analysis of data</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics</gtr:department><gtr:description>Scottish and Irish collaboration for stillbirth prevention study</gtr:description><gtr:id>0C801A2B-42F4-4C2E-9584-833682628602</gtr:id><gtr:impact>Multidisciplinary grant application - obstetrics, midwifery, statistics, sociology</gtr:impact><gtr:outcomeId>CRx85zm7nTe-2</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>I initiated this collaboration to generate a proposal and later funding for a stillbirth prevention study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics and Gynaecology</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>E84403FF-7DF6-4786-99EC-015EBE446605</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-4</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics and Gynaecology Research</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>05F8524D-691A-4845-B58D-D34E4EC2F81C</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-2</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>B4AF2965-A3B6-4C12-B476-CCC271B88B85</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-1</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Norwegian Institute of Public Health</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of International Public Health</gtr:department><gtr:description>Scottish and Irish collaboration for stillbirth prevention study</gtr:description><gtr:id>28EB875F-EFD4-4D73-AD42-97A5B2192844</gtr:id><gtr:impact>Multidisciplinary grant application - obstetrics, midwifery, statistics, sociology</gtr:impact><gtr:outcomeId>CRx85zm7nTe-3</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>I initiated this collaboration to generate a proposal and later funding for a stillbirth prevention study</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Healthcare Randomised Trials</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>A9185AB9-1775-4DAE-88ED-E4C388A5049A</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-3</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal College of Obstetricians and Gynaecologists (RCOG)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Preterm birth clinical study group</gtr:description><gtr:id>4CE5EE16-78F5-4F78-B714-29FFD0B447CA</gtr:id><gtr:impact>Collaboration is somewhat multidisciplinary in that there are paediatric, lay and midwifery members.

The collaboration has led to several other grant applications none of which have been successful so far. Another three grant applications have been submitted based on the activity of the preterm birth CSG.</gtr:impact><gtr:outcomeId>XWuztai7z45-1</gtr:outcomeId><gtr:partnerContribution>The OPPTIMUM grant and the informal collaboration which initiated this grant stimulated the RCOG to set up clinical study groups, with the Preterm Birth Clinical Study group being the exemplar of this.
The Preterm Birth CSG has provided a focus for discussion about new trials in preterm birth, and provides some support (largely in terms of a discussion forum) for ongoing trials</gtr:partnerContribution><gtr:piContribution>CI was a member of the CSG from its inception in 2008 and became Chair in 2010.
OPPTIMUM co-grantholder was Chair of the Preterm birth CSG from 2008 onwards and is now a member.
Another OPPTIMUM co-grantholder has been a member of the CSG since 2008</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>EPPPIC Collaboration</gtr:description><gtr:id>F6363B98-0FC0-4631-80FE-DC08AC355A2D</gtr:id><gtr:impact>A protocol to do an IPD.
Disciplines include statistics, patient perspectives as well as pregnancy research.</gtr:impact><gtr:outcomeId>58bc5cd5f11282.66201515-2</gtr:outcomeId><gtr:partnerContribution>March of Dimes then lobbied PCORI who subsequently commissioned and funded the project.</gtr:partnerContribution><gtr:piContribution>This was a collaboration stimulated by the publication of the OPTIMUM study, which contradicted some of the existing literature on progesterone prophylaxis to prevent preterm birth. The collaboration aims to perform an IPD of the world literature on progesterone to prevent preterm birth. The collaboration has been commissioned and funded by PCORI (the Patient Centered Research Initiative, USA). University of York are performing the IPD. I lobbied March of Dimes to set up this IPD, March of Dimes then lobbied PCORI who subsequently funded the project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Exeter</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Obstetrics &amp; Gynaecology</gtr:department><gtr:description>Collaborative group for STOPPIT 2 study</gtr:description><gtr:id>BABAD6AA-2E52-4D2F-B2D8-FF3A99FDEEEC</gtr:id><gtr:impact>Grant application not yet funded. 
Multidisciplinary:
obstetrics
statistics</gtr:impact><gtr:outcomeId>C4AjVnHRsGg-5</gtr:outcomeId><gtr:partnerContribution>Members of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:partnerContribution><gtr:piContribution>Leadership of a research team for a grant to test a device to prevent preterm labour in twins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Perinatal Ireland</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Scottish and Irish collaboration for stillbirth prevention study</gtr:description><gtr:id>5CB3A8FC-C18C-4B4F-AA5A-0FA0D3CD0AF4</gtr:id><gtr:impact>Multidisciplinary grant application - obstetrics, midwifery, statistics, sociology</gtr:impact><gtr:outcomeId>CRx85zm7nTe-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>I initiated this collaboration to generate a proposal and later funding for a stillbirth prevention study</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Federation of Gynecology and Obstetrics (FIGO)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FIGO/March of Dimes collaboration</gtr:description><gtr:id>ABC30320-203C-4F3A-B740-90885B2ADB09</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>550177e947b2d4.30007738-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contribution to questions on preterm birth causes and analysis of data
Funding of contract research organisation</gtr:partnerContribution><gtr:piContribution>Intellectual contribution to questions on preterm birth causes and analysis of data</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>An Odyssey in pregnancy research - there and back again. Inaugural Lecture, University of Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8A5A3838-9459-4E29-8A50-B7D1C9BEF8B8</gtr:id><gtr:impact>Around 150 people attended this talk

Increased awareness of issues of maternal obesity</gtr:impact><gtr:outcomeId>d2jkNVAWZS8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Progesterone for prevention of preterm birth. Gaps in current knowledge and long term effects. COGI meeting. Paris, December 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D361A972-843E-45B9-B5AF-CA549144F1DF</gtr:id><gtr:impact>Talk sparked questions and discussion</gtr:impact><gtr:outcomeId>55017f7b1de984.50456970</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Improving outcomes for pregnant women and babies in Scotland through research. Scottish Government Maternity Services Good Practice Event Edinburgh, May 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A3D76EE1-9771-4264-9F9C-6E0D9EFD6189</gtr:id><gtr:impact>Talk sparked questions and discussion afterwards

Talk sparked questions and discussion afterward</gtr:impact><gtr:outcomeId>55017dcb3496d6.99876344</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Therapy to stop premature birth safe but ineffective, study finds</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B8433678-6D00-4562-8660-0AE74F0E4D5A</gtr:id><gtr:impact>A therapy widely recommended in the UK, Europe and the US to stop babies from being born too soon is ineffective, research shows.
The treatment does not appear to pose any harm to mother or baby but has no effect on preventing an early birth, the findings reveal.
Researchers say that use of the medicine should be reviewed. They also call for a re-doubling of efforts to find alternative interventions to prevent premature births.
Previous research suggested that the therapy - a hormone called progesterone - may stop pregnant women from giving birth early but little was known about its long term effects. 
This latest trial - involving more than 1200 women - is the largest to assess the effects of the treatment on women and the first to study its effects in babies born after the therapy.
Researchers focused on women who are considered to have a greater risk of premature delivery - either because they have previously delivered a baby early or have lost a baby late in pregnancy.
Around a half of the women were given progesterone and the others were given a dummy pill.
The team found that whilst the therapy appeared to be safe, it did not reduce the risk of premature delivery and offered no notable health benefits for mother or baby.
More than 64 hospitals from around the UK were involved in the research, which was led by the Tommy's Centre for Maternal and Fetal Health at the University of Edinburgh.
The study is published in The Lancet. It was funded by the Efficacy and Mechanism Evaluation (EME) Programme, a partnership between the Medical Research Council and National Institute for Health Research.
Professor Jane Norman, Director of the Tommy's Centre for Maternal and Fetal Health at the University of Edinburgh, said: &amp;quot;Babies born too early have a much greater risk of short-term and long-term health problems. We need to find new strategies that help mums carry their babies to term.&amp;quot;</gtr:impact><gtr:outcomeId>58b996fce158a4.88493849</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Prophylactic progesterone in asymptomatic women (PRO). 1st European Spontaneous Preterm Birth Congress and 2nd PREBIC International Satellite Symposium, Svenborg, May 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>15F78819-C90A-4C6C-AD15-3DB2B1C0D150</gtr:id><gtr:impact>Talk sparked questions and discussion</gtr:impact><gtr:outcomeId>55017ee9b12ac4.70206400</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Detective Series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DF3B07B4-6825-4835-8492-B86D94BD55B8</gtr:id><gtr:impact>Audience of 100 members of the public who asked questions about research into preterm birth and its prevention.


The lecture is available on You Tube at http://www.youtube.com/watch?v=TC43j2UJ-GI&amp;amp;feature=player_embedded. As of Nov 2011 it has had 1400 hits on &amp;quot;You tube&amp;quot;.</gtr:impact><gtr:outcomeId>rpPwVCnqJDh</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inaugural lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>08FE11DC-F22B-4247-B2CF-841343244D76</gtr:id><gtr:impact>120 attendees

Interest in research into preterm birth</gtr:impact><gtr:outcomeId>tGBkyJS8o7p</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diagnosis and pharmacological management of preterm labour and birth</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D2BE055D-7208-42ED-9776-522134022555</gtr:id><gtr:impact>FIGO working group on Preterm BirthClinical Health Perspective. Presentation at FIGO (International Federation of Obstetrics and Gynaecology Meeting</gtr:impact><gtr:outcomeId>56cb0a874bb910.15039971</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centre for Reproductive Biology Public Lecture series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>27A56AF0-B5A2-4C70-9134-0B7E6AB74FC4</gtr:id><gtr:impact>250 attendees to a talk about preterm labour which included discussion of the need for clinical trials such as OPPTIMUM and how they are undertaken.
Significant discussion afterwards.

Some attendees expressed interest in medicine / research as a career</gtr:impact><gtr:outcomeId>i1dqWMq9kcX</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Preterm BirthClinical Health Perspective.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CEB299BC-CF6F-4AF9-A5ED-E869A953889F</gtr:id><gtr:impact>FIGO working group on Preterm BirthClinical Health Perspective. Presentation at FIGO (International Federation of Obstetrics and Gynaecology Meeting, Vancouver</gtr:impact><gtr:outcomeId>56cb09f2d4fbd1.65480761</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hormones, the immune system and the initation of parturition. World Congress of Reproductive Biology Meeting, Edinburgh October 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5DE9FA54-57CB-4E95-BE94-A2BD7013662A</gtr:id><gtr:impact>Qus and discussion</gtr:impact><gtr:outcomeId>55017f3b565e38.20821429</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2.	Preterm Labor - Improving Clinical Outcomes Now and in the Future</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3153A824-9159-480B-8304-72875B23C0B2</gtr:id><gtr:impact>PREBIC symposium, Society of Reproductive Investigation Meeting, San Francisco</gtr:impact><gtr:outcomeId>56cb07405ff6e8.46843533</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>	Progesterone does not prevent preterm labour (debate). European Board and College of Obstetrics and Gynaecology  meeting Glasgow, May 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D522A139-8DE6-486F-9692-2DECFB2053D6</gtr:id><gtr:impact>Talk sparked questions and discussion afterwards</gtr:impact><gtr:outcomeId>55017c35b958f3.00600670</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science Public Engagement Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7B5EBFFE-0D95-4ABA-9CEE-DB03A674321F</gtr:id><gtr:impact>Pint of Science Talk &amp;quot;Sex Drugs and Birth&amp;quot; 23.5.16</gtr:impact><gtr:outcomeId>58bc63d91b44c1.76148342</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://pintofscience.co.uk/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1364000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>My baby's movements study. NHMRC (Australia)</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:id>615EA9DA-F788-4E94-A27D-3A0C8DDA5F21</gtr:id><gtr:outcomeId>5457f2418a8066.40280100</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>990000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME- Does Metformin reduce excess birthweight in offspring of obese pregnant women</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>473CEEF6-626F-4B6C-A56C-EA367E3B6BFB</gtr:id><gtr:outcomeId>ZRHFbaWTRRo0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2050000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>Should we treat iron deficiency anaemia of pregnancy with lactoferrin? A randomised controlled trial.</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:id>A800E36D-08F5-4751-8CCD-EB09B0B98D83</gtr:id><gtr:outcomeId>5457f27bd4b207.36330069</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>145000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development gap funding -Screening efficacy of PROKR1 antagonists in the treatment of pre-term labour</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>5A521F9C-E7FF-4382-80C7-004F00E20965</gtr:id><gtr:outcomeId>KPhUvR8d7YL0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125778</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant - iNKT cells as drivers for preterm labour.</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L002647/1</gtr:fundingRef><gtr:id>EE369446-DF5F-42F2-8D17-3DDAC9D5C30C</gtr:id><gtr:outcomeId>idxTEJQojNF</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>March of Dimes - Inherited predisposition to spontaneous preterm birth. 2008-9. March of Dimes</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>March of Dimes Foundation</gtr:fundingOrg><gtr:id>326F325E-DC31-45EB-9FE0-4039CFE98ADB</gtr:id><gtr:outcomeId>Zv3eDQJgQrg0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre for Reproductive Health Centre grant</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002033</gtr:fundingRef><gtr:id>7CCE28D8-798F-4FB0-A52E-27B3168298BF</gtr:id><gtr:outcomeId>mTrWVgPse1V0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>217000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS (GRACES) - a feasibility open label randomised trial</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>866F523D-3F5C-4532-BAF7-79B28D11E2E4</gtr:id><gtr:outcomeId>5457f2085a5ff7.59983816</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Services Research Grants - AFFIRM - Does promoting increased awareness of decreased fetal movements reduce stillbirth</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>93484660-5E69-4662-BD12-0C27AA12561E</gtr:id><gtr:outcomeId>HTNTN5LP8C7</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1494000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant - Poly(A)-binding proteins highlight the importance of regulated mRNA translation and stability in determining a functional materno-fetal interface.</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MRC MR/J003069/1</gtr:fundingRef><gtr:id>76437CFD-02AD-4F0A-A407-E7A325DC9BDC</gtr:id><gtr:outcomeId>UXD6pqNhcVe</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1756618</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: A randomised placebo-controlled trial (PRISM Trial</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D86520FD-C286-42B6-A30E-191A4E1ED0DC</gtr:id><gtr:outcomeId>5457f2f7e1b6e2.93513197</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1327029</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>An open randomised trial of the Arabin pessary to prevent preterm birth in twin pregnancy - STOPPIT- 2.</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>770C777D-57D4-45EC-80F0-388C05F59D11</gtr:id><gtr:outcomeId>5457f386b555a1.92204342</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>187514</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Institutional Strategic Award Scheme</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>327B14F5-9EC2-44F7-B773-92748A2420FB</gtr:id><gtr:outcomeId>isJ81ddBPP6</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>51585</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept - Microfluidic concentration of circulating foetal nucleic acids from maternal blood</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>59FD8A69-4B50-428C-8F7A-38C6287EDF55</gtr:id><gtr:outcomeId>ANrxL9VguZv</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre funding Tommys (charity)</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Guy?s &amp; St Thomas? Charity</gtr:fundingOrg><gtr:id>66E1A565-F279-4AF2-8EF1-5C07A1DBB9FB</gtr:id><gtr:outcomeId>MBqxtipgY8T0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1090069</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Suture Type for Incompetent Cervix and effect on Health outcomes</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>6838F901-1A67-49ED-9044-EF124FD13660</gtr:id><gtr:outcomeId>5457f2b9ec0cf5.10202507</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1712000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>A pragmatic adaptive sequential placebo controlled randomised trial to determine the effectiveness of Glycerin trinitrate for retained placenta (Got-it trial).</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>6772CAEC-C6A0-4AF3-8B65-F9CEDC682B88</gtr:id><gtr:outcomeId>5457f1bde5c0e7.83750804</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Guidance on use of progesterone</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:guidelineTitle>No formal guideline title but guidance to obstetricians from the RCOG that progesterone should not be prescribed to prevent preterm birth except in randomised trials</gtr:guidelineTitle><gtr:id>D8A26F9E-D0C8-48BB-8EA4-EF19932DFAC1</gtr:id><gtr:outcomeId>GcVUSQdqe2u</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Chief Scientist Office, Scottish Executive, (HSRC) and Sands</gtr:description><gtr:id>D0979B08-283E-4072-A791-63A4FDFD9051</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56c6ffe6964e39.75084761</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>AFFIRM - Does promoting increased awareness of decreased fetal movements reduce stillbirth, a stepped wedge cluster randomised trial?</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.crh.ed.ac.uk/affirm/</gtr:url><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Chief Scientist Office, Scottish Executive.</gtr:description><gtr:id>94D8F2A0-B5A4-4FCC-BCDC-4D77CE9FCD7A</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56c70109d973f1.06127086</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS (GRACES) - a feasibility open label randomised trial</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>https://www.npeu.ox.ac.uk/graces</gtr:url><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Use of metformin to reduce birthweight centile in obese pregnant women. Clinical trial called EMPOWaR funded by NIHR / EME
Clinical trial - ISRCTN51279843</gtr:description><gtr:id>D38866B7-5489-4116-AE4E-E515E2A91B03</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>cewViLxKKMs</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>EMPOWaR</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:ukcrnIsctnId>ISRCTN51279843</gtr:ukcrnIsctnId><gtr:url>http://www.controlled-trials.com/ISRCTN51279843</gtr:url><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>National Institute of Health, Health Technology Assessment Board</gtr:description><gtr:id>F6BD6037-176A-4E7A-AFDA-4944703DD7A2</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56c701ce239312.80149211</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>An open randomised trial of the Arabin pessary to prevent preterm birth in twin pregnancy - STOPPIT- 2.</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>https://w3.abdn.ac.uk/hsru/stoppit2/</gtr:url><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BEF8DEA2-528E-4A3E-98A3-E20E11E6FE9A</gtr:id><gtr:title>Cost Effectiveness of HPV Vaccination: A Systematic Review of Modelling Approaches.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b37ca4a49d0616af26ea31242e516956"><gtr:id>b37ca4a49d0616af26ea31242e516956</gtr:id><gtr:otherNames>Pink J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>589c979a5ec310.46251678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFCD05A5-52AC-404F-9221-CB873F8B8FFB</gtr:id><gtr:title>The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>589c979580b325.96138975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27A69668-C1C3-4DE2-90D6-F54FE198CF40</gtr:id><gtr:title>The effects of a one-to-one nurse-to-patient ratio on the mortality rate in neonatal intensive care: a retrospective, longitudinal, population-based study.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1822b8a0661e7cc71b1c7d895cd852cf"><gtr:id>1822b8a0661e7cc71b1c7d895cd852cf</gtr:id><gtr:otherNames>Watson SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>589c97985b7026.07374843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>069079CB-09F2-410A-BFA8-541750454D68</gtr:id><gtr:title>Variation in management of women with threatened preterm labour.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b650a8a1a9fc360f5a286f555e156f9"><gtr:id>0b650a8a1a9fc360f5a286f555e156f9</gtr:id><gtr:otherNames>Stock SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>5501c61a081b44.34623928</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62DF61C0-681A-4B2E-8BA3-DF15703B958F</gtr:id><gtr:title>The Maps Reporting Statement for Studies Mapping onto Generic Preference-Based outcome Measures.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>589c97975952d4.99267562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C68CCD7-0461-4D83-A5F6-970F2CEB1A62</gtr:id><gtr:title>Active Treatment for Idiopathic Adolescent Scoliosis (ACTIvATeS): a feasibility study.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5b0334a16532b99f1694eddf42a962"><gtr:id>fd5b0334a16532b99f1694eddf42a962</gtr:id><gtr:otherNames>Williams MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>589c9794979d93.24313527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E029AFD-000A-4156-A883-0F0C61DFDA35</gtr:id><gtr:title>Protocol for a multicentre, parallel-arm, 12-month, randomised, controlled trial of arthroscopic surgery versus conservative care for femoroacetabular impingement syndrome (FASHIoN).</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc950d36c64381347c6a66e5332fcab0"><gtr:id>bc950d36c64381347c6a66e5332fcab0</gtr:id><gtr:otherNames>Griffin DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>589c979a9ea1f2.05891013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7108B7A3-6923-49E1-A503-55910085DCDC</gtr:id><gtr:title>Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>589c979c282595.72964765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74EB7020-9ABE-4B9D-B65A-75B0342303D9</gtr:id><gtr:title>Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7270471894f8d4438dac2945026842d"><gtr:id>f7270471894f8d4438dac2945026842d</gtr:id><gtr:otherNames>Dritsaki M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>589c979c63ac55.66010086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6453B77D-77A5-4F40-96C3-E3C7237460DE</gtr:id><gtr:title>Facet-joint injections for people with persistent non-specific low back pain (FIS): study protocol for a randomised controlled feasibility trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dafd396036c225d8ac5471fc924c4b36"><gtr:id>dafd396036c225d8ac5471fc924c4b36</gtr:id><gtr:otherNames>Sandhu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>589c9797a613b5.53172582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C569193-8F12-440B-B923-D11CD71D40A8</gtr:id><gtr:title>Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30d3f30f5f052116c9eb44fc1000debb"><gtr:id>30d3f30f5f052116c9eb44fc1000debb</gtr:id><gtr:otherNames>Wolf A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>589c979460d0a9.77209328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E88F88-0E35-40D4-9815-F925231147B7</gtr:id><gtr:title>Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>589c9795ec68e5.19410793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55F71E56-610C-43C8-BDED-527CE3C828BF</gtr:id><gtr:title>Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?</gtr:title><gtr:parentPublicationTitle>BMC pregnancy and childbirth</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15baee59240e9c8b3a9b71289ebf646b"><gtr:id>15baee59240e9c8b3a9b71289ebf646b</gtr:id><gtr:otherNames>Norman JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2393</gtr:issn><gtr:outcomeId>doi_12834_2393_12_79</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CA277DE-F7D3-4D07-A15F-2FF1482AC9CE</gtr:id><gtr:title>Neurodevelopmental outcomes following late and moderate prematurity: a population-based cohort study.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/353e752deb089a0d0e572cf98e705365"><gtr:id>353e752deb089a0d0e572cf98e705365</gtr:id><gtr:otherNames>Johnson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>589c979330fe93.16585861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2EECC4B-9BF2-471A-AA70-011C98D634D9</gtr:id><gtr:title>Psychometric properties of Patient Reported Outcome Measures (PROMs) in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS).</gtr:title><gtr:parentPublicationTitle>Health and quality of life outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e306ca1fa1e5bc11c2516b9eb484cb2d"><gtr:id>e306ca1fa1e5bc11c2516b9eb484cb2d</gtr:id><gtr:otherNames>Shah HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-7525</gtr:issn><gtr:outcomeId>589c9797e1bc12.96908208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91BC6C6D-504F-4C0E-A56B-25CBDEF6C97B</gtr:id><gtr:title>Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.</gtr:title><gtr:parentPublicationTitle>Applied health economics and health policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1175-5652</gtr:issn><gtr:outcomeId>589c9795470726.79024223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CEEA6D4-C0BD-4CF4-8793-CF23C756DD64</gtr:id><gtr:title>Immune cells and preterm labour: do invariant NKT cells hold the key?</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e39684739d81aa8b533b15fd44bdf98"><gtr:id>3e39684739d81aa8b533b15fd44bdf98</gtr:id><gtr:otherNames>Rinaldi SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>5506fee74438d7.22256139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92A1D6BE-89C0-47DC-8507-3C3508ECEBB0</gtr:id><gtr:title>UK Fixation of Distal Tibia Fractures (UK FixDT): protocol for a randomised controlled trial of 'locking' plate fixation versus intramedullary nail fixation in the treatment of adult patients with a displaced fracture of the distal tibia.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45999bf78d87b20e92c9869e281356a7"><gtr:id>45999bf78d87b20e92c9869e281356a7</gtr:id><gtr:otherNames>Achten J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>589c9796d06068.20827945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28FB65A7-7A27-43E2-A743-ED68B540D7F5</gtr:id><gtr:title>Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6175a0811957dbee74973f6514cae70a"><gtr:id>6175a0811957dbee74973f6514cae70a</gtr:id><gtr:otherNames>Maheswaran H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>589c979896a233.81503761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23F1175A-975B-4C0E-A0F0-C0E01962F7CF</gtr:id><gtr:title>Pre-hospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest (PARAMEDIC-2): Trial protocol.</gtr:title><gtr:parentPublicationTitle>Resuscitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/746bb30afe66da438f82826eb311c7bd"><gtr:id>746bb30afe66da438f82826eb311c7bd</gtr:id><gtr:otherNames>Perkins GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-9572</gtr:issn><gtr:outcomeId>589c979ad3b003.02912801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4210D2-FC42-48AE-9C13-B2FB89278890</gtr:id><gtr:title>Associations between late and moderately preterm birth and smoking, alcohol, drug use and diet: a population-based case-cohort study.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e36bf0b8eaa4a2f37905dd114933835"><gtr:id>4e36bf0b8eaa4a2f37905dd114933835</gtr:id><gtr:otherNames>Smith LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>589c9793df5543.26041353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94E10863-98F7-4678-A2D5-313C0BC25EB7</gtr:id><gtr:title>Protocol for a randomised controlled trial of standard wound management versus negative pressure wound therapy in the treatment of adult patients with an open fracture of the lower limb: UK Wound management of Lower Limb Fractures (UK WOLLF).</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45999bf78d87b20e92c9869e281356a7"><gtr:id>45999bf78d87b20e92c9869e281356a7</gtr:id><gtr:otherNames>Achten J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>589c9797198188.44147237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00385F2B-E181-418F-BFA4-A932C4A82E87</gtr:id><gtr:title>An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.</gtr:title><gtr:parentPublicationTitle>Health and quality of life outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7270471894f8d4438dac2945026842d"><gtr:id>f7270471894f8d4438dac2945026842d</gtr:id><gtr:otherNames>Dritsaki M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1477-7525</gtr:issn><gtr:outcomeId>589c979c98a800.38751158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22FD6B1C-2CB1-4467-9454-46A1AFB9B30A</gtr:id><gtr:title>Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.</gtr:title><gtr:parentPublicationTitle>Journal of medical economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1369-6998</gtr:issn><gtr:outcomeId>589c97969d5c54.27900230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E2AAC0-FA15-4BDA-B730-F1C539497204</gtr:id><gtr:title>Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.</gtr:title><gtr:parentPublicationTitle>Health and quality of life outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1477-7525</gtr:issn><gtr:outcomeId>589c979633d0c3.00737148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FF98818-32CF-4DF2-B591-FEE9FB55E7E8</gtr:id><gtr:title>Mode of Delivery and Long-Term Health-Related Quality-of-Life Outcomes: A Prospective Population-Based Study.</gtr:title><gtr:parentPublicationTitle>Birth (Berkeley, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0730-7659</gtr:issn><gtr:outcomeId>589c979b14cbc1.33178990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD50461B-648B-4161-999A-0D2E195EB61F</gtr:id><gtr:title>A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8068e3fbc14cc4061c5160e12bee22"><gtr:id>0c8068e3fbc14cc4061c5160e12bee22</gtr:id><gtr:otherNames>Marlow N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>589c9793ac4054.46608059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52813B19-805B-4C42-800A-C16313C91F61</gtr:id><gtr:title>Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7a4b9ba86740fe55c8579d4e8e8ab47"><gtr:id>d7a4b9ba86740fe55c8579d4e8e8ab47</gtr:id><gtr:otherNames>Husereau D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>589c979379dfb3.62536715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13EDECDB-DBAE-4E34-ADDB-304E75655D6F</gtr:id><gtr:title>Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement.</gtr:title><gtr:parentPublicationTitle>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-9343</gtr:issn><gtr:outcomeId>589c979511fc72.94590538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FD9855F-7706-4AB1-8B84-02D57F733CEA</gtr:id><gtr:title>PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT.</gtr:title><gtr:parentPublicationTitle>International journal of technology assessment in health care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0266-4623</gtr:issn><gtr:outcomeId>589c979664b267.11258480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E8EF099-B26E-4F11-81B6-68C2D3C469E7</gtr:id><gtr:title>Preterm labour: summary of NICE guidance.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0b90d9546b4ad9c2c2e321773437909"><gtr:id>c0b90d9546b4ad9c2c2e321773437909</gtr:id><gtr:otherNames>Sarri G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>56c704d26b2ce1.00054628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6479C8E-0C52-42AB-BD9A-22289603C2AC</gtr:id><gtr:title>Economic costs associated with moderate and late preterm birth: a prospective population-based study.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4675fb4f85239ea626dfd4dcc38812"><gtr:id>1c4675fb4f85239ea626dfd4dcc38812</gtr:id><gtr:otherNames>Khan KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>589c9794d1e552.85350323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18B2473E-7E1F-46B6-9767-ADD005528D75</gtr:id><gtr:title>Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b1316e0c841c5aa8904d08fca77bc82"><gtr:id>1b1316e0c841c5aa8904d08fca77bc82</gtr:id><gtr:otherNames>Atherton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>589c9799e84525.37960553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D43F9322-12E4-4B45-85F4-CB2A88D4E9C4</gtr:id><gtr:title>Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6333239b7895af3436eeb0d70e2c1bea"><gtr:id>6333239b7895af3436eeb0d70e2c1bea</gtr:id><gtr:otherNames>Shiri T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>589c979b4bac84.37554888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>645759AF-C8B1-443F-8936-8981322B97CD</gtr:id><gtr:title>Self-reported health and socio-economic inequalities in England, 1996-2009: Repeated national cross-sectional study.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6175a0811957dbee74973f6514cae70a"><gtr:id>6175a0811957dbee74973f6514cae70a</gtr:id><gtr:otherNames>Maheswaran H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>589c9794282761.60646203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>446FAEE7-1F43-4423-96F1-E8A05D155872</gtr:id><gtr:title>Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15baee59240e9c8b3a9b71289ebf646b"><gtr:id>15baee59240e9c8b3a9b71289ebf646b</gtr:id><gtr:otherNames>Norman JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>589c9799b79ca8.88826776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8018D1FB-AFB5-4F95-850D-3A3E479A65EB</gtr:id><gtr:title>Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53407c3bb64bb10439102760fe13e298"><gtr:id>53407c3bb64bb10439102760fe13e298</gtr:id><gtr:otherNames>Robertson W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>589c979be7a535.85287057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10FAF9C1-A6D3-4568-B9DA-0751F3930A6B</gtr:id><gtr:title>Immune cell and transcriptomic analysis of the human decidua in term and preterm parturition.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e39684739d81aa8b533b15fd44bdf98"><gtr:id>3e39684739d81aa8b533b15fd44bdf98</gtr:id><gtr:otherNames>Rinaldi SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>5a8ab53f28e613.17394026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DE7AB04-3851-4114-ADB4-C40DC264A210</gtr:id><gtr:title>Neonatal outcomes and delivery of care for infants born late preterm or moderately preterm: a prospective population-based study.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e125d4722a3d988826c703ab361d630"><gtr:id>8e125d4722a3d988826c703ab361d630</gtr:id><gtr:otherNames>Boyle EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>589c9792e4c4e4.59389159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1EE6A57-0700-4599-BB92-7263CE727CF1</gtr:id><gtr:title>Prevention of preterm birth--why can't we do any better?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15baee59240e9c8b3a9b71289ebf646b"><gtr:id>15baee59240e9c8b3a9b71289ebf646b</gtr:id><gtr:otherNames>Norman JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>doi_12834_12_61956_4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67E34EB3-FFC6-4A69-919A-6D31A76EA476</gtr:id><gtr:title>Randomised controlled trial and economic evaluation of the 'Families for Health' programme to reduce obesity in children.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53407c3bb64bb10439102760fe13e298"><gtr:id>53407c3bb64bb10439102760fe13e298</gtr:id><gtr:otherNames>Robertson W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>589c979baf0ff3.64887626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA62AE84-1B9B-4A60-89DF-29668D02A677</gtr:id><gtr:title>Economic evaluation of nebulized magnesium sulphate in acute severe asthma in children.</gtr:title><gtr:parentPublicationTitle>International journal of technology assessment in health care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9d9a354316deee059d8fb5f6596c24e"><gtr:id>a9d9a354316deee059d8fb5f6596c24e</gtr:id><gtr:otherNames>Petrou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0266-4623</gtr:issn><gtr:outcomeId>589c97926a09e9.75680775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19CE1A35-2D23-4B3D-A5E7-082B2B84CD20</gtr:id><gtr:title>Outpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7a6ee694f79afba5f3611baf500181f"><gtr:id>f7a6ee694f79afba5f3611baf500181f</gtr:id><gtr:otherNames>Cooper NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>589c9792a3bd05.83406310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A8D96BD-7826-4966-81DA-9313A71620DB</gtr:id><gtr:title>Economic and Health-Related Quality of Life Outcomes of Whiplash Associated Disorders.</gtr:title><gtr:parentPublicationTitle>Spine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b37ca4a49d0616af26ea31242e516956"><gtr:id>b37ca4a49d0616af26ea31242e516956</gtr:id><gtr:otherNames>Pink J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0362-2436</gtr:issn><gtr:outcomeId>589c979983fb59.65394822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC6CE2E2-6402-4673-936C-817BE07C9A9B</gtr:id><gtr:title>UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/722ef402526ece9d7687d6a787320e34"><gtr:id>722ef402526ece9d7687d6a787320e34</gtr:id><gtr:otherNames>Griffin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>589c979a2733a4.64374955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>405046B2-E6E3-4401-8286-62255E7CE460</gtr:id><gtr:title>Fetal assessment methods for improving neonatal and maternal outcomes in preterm prelabour rupture of membranes.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1aff7fbc17b044e81e5ad2ae5977629"><gtr:id>b1aff7fbc17b044e81e5ad2ae5977629</gtr:id><gtr:otherNames>Sharp GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>5457545594d0d8.24732666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE0511F6-E10D-46E5-BF4D-6467D8AEEAEB</gtr:id><gtr:title>Gestational age and hospital utilization: three-years follow-up of an area-based birth cohort.</gtr:title><gtr:parentPublicationTitle>Annali dell'Istituto superiore di sanita</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfa88d2048c1dfb0e7f0c2f5b3b7eda6"><gtr:id>dfa88d2048c1dfb0e7f0c2f5b3b7eda6</gtr:id><gtr:otherNames>Corchia C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-2571</gtr:issn><gtr:outcomeId>589c979b8041b1.51875328</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700452</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>